drugset / Trial / NCT03745001
To Evaluate the Safety and Tolerability, Pharmacokinetics, Food-effect and Pharmacodynamics of EHP-101 in Healthy Volunteers
RandomizedParallel-groupDouble-blindTreatment
Summary
The study will assess the safety and tolerability, pharmacodynamic, pharmacokinetic profiles, and food effect of single ascending doses and multiple ascending doses (7 consecutive days) after daily oral administration in healthy male and female subjects.
Timeline
- Start
- 2018-09-14
- Primary completion
- 2019-08-11
- Completion
- 2019-09-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ETRINABDIONE | Small molecule | 0.91 mg | Oral |
| Subject | ETRINABDIONE | Small molecule | 200 mg | Oral |
Indications
No indication recorded.